1-Azabicyclo[3.2.0]heptane-2-carboxylic acid, 6-[(1R)-1-hydroxyethyl]-4-methyl-3,7-dioxo-, (4-nitrophenyl)methyl ester, (4R,5R,6S)- → HCID 22839796, compound
Reaction equation
[OH:1][C@@H:2]([C@H:4]1[C:25](=[O:26])[N:6]2[CH:7]([C:12]([O:14]CC3C=CC([N+]([O-])=O)=CC=3)=[O:13])[C:8](=O)[C@H:9]([CH3:10])[C@H:5]12)[CH3:3].Cl.[CH3:28][N:29]1[CH2:34][CH2:33][N:32]([C:35](=[NH:38])[CH2:36][SH:37])[CH2:31][C:30]1=[O:39]>>[CH3:28][N:29]1[CH2:34][CH2:33][N:32]([C:35](=[NH:38])[CH2:36][S:37][C:8]2[C@H:9]([CH3:10])[C@@H:5]3[C@@H:4]([C@H:2]([OH:1])[CH3:3])[C:25](=[O:26])[N:6]3[C:7]=2[C:12]([OH:14])=[O:13])[CH2:31][C:30]1=[O:39]Participants
3
Procedure
The procedure of Example 1(3) was repeated, except that 100 mg of p-nitrobenzyl (1R,5R,6S)-6-[(1R)-1-hydroxyethyl]-1-methyl-2-oxo-1-carbapenam-3-carboxylate and 90 mg of 2-(4-methyl-3-oxopiperazin-1-yl)-2-iminoethylmercaptan hydrochloride were used. After hydrogenation and filtration over "Celite" (Trade Mark) filter aid, the filtrate was extracted twice with 20 ml portions of diethyl ether. The aqueous phase was concentrated by evaporation under reduced pressure, and the residue was purified by chromatography through a Lobar column (Merck "LiChloprep RP-8", size B, two columns), eluted with 2% aqueous methanol, to give 10 mg of the title compound.
Workup
- filtrationAfter hydrogenation and filtration over "Celite" (Trade Mark)
- filtrationfilter aid
- extractionthe filtrate was extracted twice with 20 ml portions of diethyl ether
- concentrationThe aqueous phase was concentrated by evaporation under reduced pressure
- customthe residue was purified by chromatography through a Lobar column (Merck "LiChloprep RP-8", size B, two columns)
- washeluted with 2% aqueous methanol
Sources & evidence
- ORD record
- ord-9561b47bc70946deaf0118774fb90e61
- Source dataset
- uspto-grants-1988_09
- Patent number
- US04771046
Reaction notes
Loading…